These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3902988)

  • 41. Dracorhodin perchlorate inhibits biofilm formation and virulence factors of Candida albicans.
    Yang LF; Liu X; Lv LL; Ma ZM; Feng XC; Ma TH
    J Mycol Med; 2018 Mar; 28(1):36-44. PubMed ID: 29477784
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The primary structure of pepstatin-insensitive carboxyl proteinase produced by Pseudomonas sp. No. 101.
    Hayashi K; Izu H; Oda K; Fukuhara K; Matsuo M; Takano R; Hara S
    J Biochem; 1995 Oct; 118(4):738-44. PubMed ID: 8576087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of pepstatin A on Candida albicans infection in the mouse].
    Zotter C; Haustein UF; Schönborn C; Grimmecke HD; Wand H
    Dermatol Monatsschr; 1990; 176(2-3):189-98. PubMed ID: 2194852
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A study of the antifungal activity of LY121019, a new echinocandin derivative.
    Strippoli V; D'Auria FD; Simonetti N
    Chemioterapia; 1988 Feb; 7(1):33-7. PubMed ID: 3288366
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Isolation and some properties of an acid protease from Fasciola hepatica.
    Rupova L; Keilová H
    Z Parasitenkd; 1979; 61(1):83-91. PubMed ID: 44401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of hyphal growth of Candida albicans by activated lansoprazole, a novel benzimidazole proton pump inhibitor.
    Biswas SK; Yokoyama K; Kamei K; Nishimura K; Miyaji M
    Med Mycol; 2001 Jun; 39(3):283-5. PubMed ID: 11446532
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An evaluation of the antifungal effect of bifonazole on Torulopsis glabrata and Candida albicans under various in vitro test conditions.
    Barug D; Bastiaanse HB
    Arzneimittelforschung; 1983; 33(4):524-8. PubMed ID: 6409128
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of the effects of Lawsonia inermis (Iranian henna) and clotrimazole on Candida albicans in rats.
    Yaralizadeh M; Abedi P; Namjoyan F; Fatahinia M; Nezamivand Chegini S
    J Mycol Med; 2018 Sep; 28(3):419-423. PubMed ID: 29891221
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Candida albicans possesses Sap7 as a pepstatin A-insensitive secreted aspartic protease.
    Aoki W; Kitahara N; Miura N; Morisaka H; Yamamoto Y; Kuroda K; Ueda M
    PLoS One; 2012; 7(2):e32513. PubMed ID: 22384266
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of fluconazole effect on Candida albicans viability during extended incubations.
    Sohnle PG; Hahn BL; Fassel TA; Kushnaryov VM
    Med Mycol; 1998 Feb; 36(1):29-36. PubMed ID: 9776809
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antifungal activity of Morinda citrifolia fruit extract against Candida albicans.
    Jainkittivong A; Butsarakamruha T; Langlais RP
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):394-8. PubMed ID: 19716507
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Environmental pH influences Candida albicans biofilms regarding its structure, virulence and susceptibility to fluconazole.
    de Vasconcellos AA; Gonçalves LM; Del Bel Cury AA; da Silva WJ
    Microb Pathog; 2014; 69-70():39-44. PubMed ID: 24685701
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fungicidal activity of latex sap from Carica papaya and antifungal effect of D(+)-glucosamine on Candida albicans growth.
    Giordani R; Cardenas ML; Moulin-Traffort J; Régli P
    Mycoses; 1996; 39(3-4):103-10. PubMed ID: 8767002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pepstatin A induces extracellular acidification distinct from aspartic protease inhibition in microglial cell lines.
    Okada M; Irie S; Sawada M; Urae R; Urae A; Iwata N; Ozaki N; Akazawa K; Nakanishi H
    Glia; 2003 Aug; 43(2):167-74. PubMed ID: 12838508
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preparation and preliminary characterization of poly(ethylene glycol)-pepstatin conjugate.
    Brygier J; Vincentelli J; Nijs M; Guermant C; Paul C; Baeyens-Volant D; Looze Y
    Appl Biochem Biotechnol; 1994 Apr; 47(1):1-10. PubMed ID: 8203868
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential expression of Candida dubliniensis-secreted aspartyl proteinase genes (CdSAP1-4) under different physiological conditions and during infection of a keratinocyte culture.
    Loaiza-Loeza S; Parra-Ortega B; Cancino-Díaz JC; Illades-Aguiar B; Hernández-Rodríguez CH; Villa-Tanaca L
    FEMS Immunol Med Microbiol; 2009 Aug; 56(3):212-22. PubMed ID: 19538512
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative ability of various prescription and over-the-counter topical antifungal drug products to inhibit the growth of C. albicans.
    Miner N; Armstrong M
    Adv Wound Care; 1994 Nov; 7(6):53, 55-6. PubMed ID: 7795865
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Triangular gold nanoparticles conjugated with peptide ligands: a new class of inhibitor for Candida albicans secreted aspartyl proteinase.
    Jebali A; Hajjar FH; Hekmatimoghaddam S; Kazemi B; De La Fuente JM; Rashidi M
    Biochem Pharmacol; 2014 Aug; 90(4):349-55. PubMed ID: 24887590
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lithium-mediated suppression of morphogenesis and growth in Candida albicans.
    Martins LF; Montero-Lomelí M; Masuda CA; Fortes FS; Previato JO; Mendonça-Previato L
    FEMS Yeast Res; 2008 Jun; 8(4):615-21. PubMed ID: 18373681
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Isolation and properties of extracellular proteinases from Sporothrix schenckii.
    Tsuboi R; Sanada T; Takamori K; Ogawa H
    J Bacteriol; 1987 Sep; 169(9):4104-9. PubMed ID: 3305479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.